TapImmune Inc. (TPIV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile by GlobalData

VIEWS: 0 PAGES: 24

More Info
									        TapImmune Inc. (TPIV) - Pharmaceuticals & Healthcare - Deals and Alliances
                                        Profile
       Reference Code: GDPH81869D                                                                                                             Publication Date: JAN 2013

      Company Overview                                                                                        Key Facts
      TapImmune Inc. (TapImmune) is a biotechnology company, based in the US. The
                                                                                                              TapImmune Inc., Pharmaceuticals & Healthcare,
      company develops vaccines and therapeutics in the areas of oncology and
                                                                                                              Key Facts, 2011
      infectious disease. It has developed TAP vaccine which executes antigens to the
      surfaces of cells and acts as an adjuvant to improve targeted vaccines against                           Web Address                         www.tapimmune.com
      infectious diseases. Taplmmune’s research capabilities and technologies were
                                                                                                               Revenue (US$ million)                                   0
      featured on ABC News BusinessNow, Cancer Research, BusinessWeek,
      International Journal of Cancer, Journal of Immunology, Nature (Biotechnology), and                      Number of Employees                              NA
      PLoS Pathogens. The company has acquired three follow-on inventions and IP                               GlobalData
      relating to TAP technology.

      Financial Deals Landscape
        TapImmune Inc., Pharmaceuticals & Healthcare, Deals by Type,                      TapImmune Inc., Pharmaceuticals & Healthcare, Deals By
        2007 to YTD 2013                                                                  Year, 2007 to YTD 2013

                                                                                                          5
                                                                                                                                          4
                                                                                                          4

                                                                                           No. of Deals
                                                                                                                                   3
                                                                                                          3

                                                                                                          2
                                                                                                                 1        1                        1      1
                                                                                                          1
                                                                                                                                                                   0
                                                                                                          0
                                                                                                               2007     2008   2009      2010     2011   2012   YTD
                                                                                                                                                                2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from        from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         TapImmune Inc., Pharmaceuticals & Healthcare, Deals By                           TapImmune Inc., Pharmaceuticals & Healthcare, Deals By
         Region, 2007 to YTD 2013                                                         Therapy Area, 2007 to YTD 2013

                         12                                                                               8               7               7
          No. of Deals




                         10     11
                          8
                                                                                           No. of Deals




                                                                                                          6
                          6
                          4                                                                               4
                                         1
                          2                       0         0        0
                          0
                              North    Europe   Asia-     Middle   South                                  2                                               1
                              Americ            Pacific    East     and
                                a                          and     Central                                0
                                                          Africa   Americ                                             Infectious       Oncology        Immunolog
                                                                     a                                                 Disease                             y


         Note: Deals include all announced pharmaceuticals & healthcare deals             Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    from 2006 onwards, GlobalData




TapImmune Inc. - Pharmaceuticals & Healthcare - Deals and                                                                                         Reference Code: GDPH81869D
Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                 Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       TapImmune Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013........................................................................ 3
       TapImmune Inc., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ........................................................................ 5
       TapImmune Inc., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 .................................................................... 6
       TapImmune Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013.......................................................... 7
       TapImmune Inc., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 ..................................................................... 8
       TapImmune Inc., Pharmaceuticals & Healthcare, Deal Details .......................................................................................................... 9
          Asset Purchase............................................................................................................................................................................... 9
             TapImmune Acquires Three Intellecutal Properties From The University of British Columbia .................................................... 9
             TapImmune Acquires TAP Technology From The University of British Columbia..................................................................... 10
             TapImmune Acquires TAP Technology From The University Of British Columbia .................................................................... 11
          Partnerships.................................................................................................................................................................................. 12
             TapImmune Enters Into Research Agreement With Mayo Clinic .............................................................................................. 12
          Licensing Agreements .................................................................................................................................................................. 13
             TapImmune Enters Into Licensing Agreement With Mayo Foundation For HER2/neu Antigen Technology ............................. 13
             TapImmune Enters Into License Option Agreement With Mayo Clinic ...................................................................................... 14
             TapImmune Enters Into License Agreement With Crucell ......................................................................................................... 15
          Equity Offering .............................................................................................................................................................................. 16
             TapImmune Completes Private Placement For $1.16 Million.................................................................................................... 16
             TapImmune Completes Private Placement For $1.3 Million...................................................................................................... 17
             TapImmune Completes Private Placement Of $1 Million .......................................................................................................... 18
          Debt Offering ................................................................................................................................................................................ 19
             TapImmune Completes Private
								
To top